Benchmark Electronics, Inc.

Benchmark Electronics, Inc. (BHE) Market Cap

Benchmark Electronics, Inc. has a market capitalization of .

No quote data available.

CEO: David Moezidis

Sector: Technology

Industry: Hardware, Equipment & Parts

IPO Date: 1990-06-27

Website: https://www.bench.com

Benchmark Electronics, Inc. (BHE) - Company Information

Market Cap: -|Sector: Technology

Company Profile

Benchmark Electronics, Inc., together with its subsidiaries, operates as a global provider, delivering a comprehensive suite of product design, engineering, technology solutions, and manufacturing services across the Americas, Asia, and Europe. Its capabilities span engineering and technology solutions, encompassing initial product design, prototyping, and comprehensive testing. This includes specialized custom testing setups and the development and construction of automation equipment. Furthermore, Benchmark excels in electronics manufacturing and rigorous testing. This involves the assembly and testing of printed circuit boards and subsystems, alongside thorough evaluations of circuitry and functionality. Their quality assurance extends to environmental, stress, and component reliability assessments, complemented by component engineering, manufacturing defect analysis, in-circuit testing, functional testing, lifecycle testing, and detailed failure analysis. The company also offers precision machining and electromechanical assembly, coupled with comprehensive subsystem and full system integration services that encompass assembly, configuration, and testing across diverse industrial sectors. Beyond core manufacturing, Benchmark provides value-added support systems, comprehensive supply chain management solutions, and direct order fulfillment. Crucially, they offer extensive aftermarket, non-warranty services that span a product's entire lifecycle, including repair, replacement, refurbishment, remanufacturing, exchange programs, system upgrades, and the production of spare parts. The company's clientele primarily consists of Original Equipment Manufacturers (OEMs) across critical sectors such as aerospace and defense, medical technologies, complex industrial applications, semiconductor capital equipment, telecommunications, and advanced computing. Benchmark promotes its services and solutions predominantly through a dedicated direct sales force. Established in 1979, the firm, previously known as Electronics, Inc., maintains its headquarters in Tempe, Arizona.

Analyst Sentiment

78%
Strong Buy

From 3 Active Polls

1Y Forecast: $91.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$90

Median

$91

High Bound

$92

Average

$91

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$91.00
▲ +14.08% Upside
Low Target
$90.00
13% Risk
Median Target
$91.00
14% Mid
High Target
$92.00
15% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 BENCHMARK ELECTRONICS INC (BHE) — Investment Overview

🧩 Business Model Overview

Benchmark Electronics Inc. operates in the Electronics Manufacturing Services (“EMS”) ecosystem, pairing engineering/design capabilities with manufacturing and supply-chain execution for mission-critical end markets. The value chain typically spans: (1) customer product development support and design-for-manufacturability, (2) new product introduction (NPI) through prototype-to-production transition, and (3) volume manufacturing and lifecycle support (spares/repairs and program continuity where applicable).

Customer stickiness tends to build over time because qualification, process documentation, quality systems, and supplier readiness require substantial effort; once an EMS provider is “designed in,” production programs often persist across product cycles.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated from contract manufacturing and engineering/production support tied to customer programs. Monetisation is less about pure hardware pass-through and more about the realized mix between:

  • NPI / engineering-led work (often higher value capture than commoditized assembly)
  • Manufacturing services (driven by utilization, yields, labor efficiency, and supply-chain execution)
  • Program-based or lifecycle revenue (manufacturing continuity and support where qualification carries forward)

Margin drivers generally include (1) the degree of content under Benchmark’s control (process complexity, test/verification, systems integration), (2) purchasing effectiveness and component logistics, (3) stable production volumes that support utilization, and (4) the ability to manage ramp risk during production transitions.

🧠 Competitive Advantages & Market Positioning

Benchmark’s durable advantage is best understood as high switching costs created by program qualification, reinforced by operational and quality barriers.

  • Switching costs (hard-to-replace qualification): When Benchmark’s processes, test/validation procedures, and supplier readiness are accepted for a program—particularly in regulated or safety-critical contexts—customers face meaningful re-qualification and schedule risk to change vendors.
  • Quality and compliance barriers (intangible moats): Certifications, disciplined documentation, and proven reliability support participation in stringent aerospace/defense and medical-adjacent programs, raising the bar for entrants.
  • Cost advantages from execution: Competitive EMS economics typically hinge on yields, automation where appropriate, efficient labor deployment, and supply-chain performance. Benchmark’s ability to manage complexity can translate into better gross margins versus peers focused more heavily on lower-margin, commoditized assembly.

Competitive benchmarking: Benchmark Electronics competes primarily with broad EMS and engineering-capable manufacturers such as Flex, Jabil, and Sanmina. These rivals frequently compete across a wider set of consumer and enterprise end markets, sometimes emphasizing scale-driven manufacturing footprints and diversified customer bases. Benchmark’s positioning emphasizes industry-specific program participation (notably aerospace/defense and complex industrial/medical-adjacent programs), where qualification-driven stickiness is more prominent than in purely commoditized electronics.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, the core opportunity set is tied to secular demand for complex electronics and the ongoing shift toward outsourced engineering + manufacturing for high-reliability systems. Key drivers include:

  • Mission-critical electronics demand: Growth in aerospace/defense electronics content and modernization programs supports longer-lived supply relationships and recurring build requirements.
  • Industrial and platform electrification: Increasing electronics content in industrial equipment raises the addressable scope for EMS providers capable of test, validation, and lifecycle support.
  • Medical and regulated systems complexity: Medical device and adjacent electronics outsourcing tends to favor providers with robust quality systems and documentation maturity.
  • Supply-chain resilience and nearshoring: Customers continue to manage sourcing concentration risk and logistics complexity, supporting demand for capable contract manufacturers with proven execution.

TAM expansion is further reinforced by a structural preference for suppliers that can manage the full transition from NPI to volume production while sustaining yields and reliability.

⚠ Risk Factors to Monitor

  • Program concentration and timing risk: EMS earnings can be sensitive to customer program starts/stops, ramp schedules, and production mix changes.
  • Component price and availability volatility: Even when costs are partially pass-through, timing mismatches and demand swings can pressure margins and working capital.
  • Capacity utilization and margin cyclicality: Operating leverage is meaningful; underutilization can compress profitability.
  • Quality, compliance, and product lifecycle risk: In regulated end markets, defects or non-compliance can create warranty, remediation, or customer program consequences.
  • Geopolitical and trade restrictions: Export controls, supply restrictions, and tariffs can alter sourcing strategies and cost structures.

📊 Valuation & Market View

In EMS and contract manufacturing, valuation frameworks often emphasize EV/EBITDA (or EV/EBIT) and, for growth-oriented profiles, P/S. Markets typically pay attention to:

  • Durability of margin structure (mix of engineering vs. pure assembly, operating leverage, and yield performance)
  • Conversion from engineering to production (NPI success rate and program ramp quality)
  • Cash flow quality (working capital discipline and capex intensity)
  • Customer and end-market mix (risk of concentration and cyclicality)

For investors, the valuation “needle movers” tend to be evidence of sustained program wins, stable production volumes, and consistent conversion from backlog/design activity into margin-accretive manufacturing.

🔍 Investment Takeaway

Benchmark Electronics’ investment case rests on qualification-driven switching costs, supported by quality/compliance barriers and execution-based cost advantages in complex, mission-critical electronics. Compared with more generalist EMS peers, Benchmark’s industry focus and program participation profile can improve customer stickiness and sustain a healthier mix of value-added work—provided it continues to manage ramp risk, working capital, and end-market cyclicality.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"BHE reported Q2 2026 revenue of $756.0M and net income of $19.9M (EPS $0.55). YoY, revenue rose +17.7% (vs. $642.3M in Q2’25) and net income jumped to $19.9M from $1.0M (up +~1,946%). QoQ, revenue increased +11.6% (from $677.3M in Q1’26) and net income rose +52.8% (from $13.0M). Profitability improved: net margin expanded to 2.63% from 1.92% QoQ and 0.15% YoY, with operating income margin also edging up to ~4.00%. Cash flow quality strengthened in Q2: operating cash flow was $34.7M and free cash flow was $24.2M, a positive shift from Q1 FCF of $28.8M despite weaker working capital (change in working capital was -$17.8M). Balance sheet resilience looks solid—total assets increased to $2.21B and equity remained stable at $1.12B, with net debt still deeply negative (net debt -$214.8M), indicating excess liquidity. Shareholder returns appear strong: shares are up +83.6% over the last year (high momentum), and the dividend yield is modest (~0.17%). Valuation remains demanding on earnings (P/E ~44x), but operating leverage and accelerating earnings support the recent rerating."

Revenue Growth

Strong

Revenue +11.6% QoQ to $756.0M and +17.7% YoY versus $642.3M; steady upward trajectory across the last two sequential quarters.

Profitability

Good

Net margin expanded to 2.63% (from 1.92% QoQ and 0.15% YoY). Net income grew +52.8% QoQ and +~1,946% YoY; EPS rose to $0.55.

Cash Flow Quality

Positive

Q2 operating cash flow was $34.7M with free cash flow of $24.2M; working capital was a headwind (-$17.8M). Still, FCF remained positive and supports earnings.

Leverage & Balance Sheet

Good

Net debt improved/was strongly negative (net debt -$214.8M) with equity stable around $1.12B. Total assets rose to $2.21B, implying balance sheet growth without obvious stress.

Shareholder Returns

Strong

Strong momentum: +83.6% 1Y price change. Dividend yield is small (~0.17%), but buybacks reduced shares (repurchased $5.8M in Q2). Total return is likely dominated by capital appreciation.

Analyst Sentiment & Valuation

Neutral

Valuation looks elevated (P/E ~44x; price-to-sales ~4.68x). Price target consensus ($86) is above the provided price context ($65.05), implying upside, but earnings multiple suggests expectations are high.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

BHE delivered a strong Q2 with revenue up 18% YoY to $756M and non-GAAP EPS up 36% YoY to $0.75, both above the prior guidance high. Margin expansion was material: gross margin rose 30 bps YoY (to 10.5%) and operating margin rose 50 bps YoY (to 5.2%), driven primarily by volume and revenue leverage despite higher variable compensation. Management increased 2026 revenue guidance to ~$3.0B (~13% growth), signaling confidence in sustained demand across most segments. Operational momentum is supported by working-capital improvement (cash conversion cycle down to 59 days) and ongoing capacity adds in Penang and Thailand. Demand catalysts were segment-specific: Semi-Cap benefited from program wins; Industrial from Phoenix wind-down timing and competitive share gains; Medical from demand pickup plus a lift-and-shift competitive win; AC&C ramped an AI-related program. Key risk remains supply-chain tightness, with lead times worsening for complex/fab-dependent components, but management highlighted proactive mitigation.

AI IconGrowth Catalysts

  • AC&C revenue growth driven by production ramp of an AI-related program win referenced in prior quarters
  • Semi-Cap demand improvement throughout Q2 with momentum continuing into Q3, supported by program wins secured during the last downturn
  • Industrial revenue acceleration benefiting from planned wind down of the Phoenix facility
  • Medical improvement supported by overall demand pick-up plus competitive takeaway (lift-and-shift engagement) shortening time to revenue
  • A&D bookings leading in Q2; optimism supported by continued bookings despite Q2 sector revenue decline

Business Development

  • Competitive takeaway in Industrial (customer-specific name not provided) enabling share-of-wallet increase via execution and new creative solutions
  • Competitive takeaway in Medical (lift-and-shift engagement; customer name not provided) improving time to revenue
  • AI-related program wins contributing to AC&C ramp (program/customer identity not provided)

AI IconFinancial Highlights

  • Revenue $756M, +18% YoY; non-GAAP EPS $0.75, +36% YoY; both above the high end of prior guidance range
  • Non-GAAP gross margin 10.5%, +30 bps YoY and +20 bps sequentially, primarily from volume
  • Non-GAAP operating margin 5.2%, +50 bps YoY and +40 bps sequentially; increase driven by higher revenue partially offset by increased variable compensation
  • Non-GAAP effective tax rate 26.6% (Q2)
  • Q3 guidance: revenue $755M-$795M (+14% YoY at midpoint); non-GAAP EPS $0.76-$0.82
  • Q3 margin guidance: gross margin 10.5%-10.7%; operating margin 5.3%-5.5%; Q3 effective tax rate 26%-27%
  • Capital structure/work-cap: cash conversion cycle 59 days, improved 26 days YoY and 8 days sequentially; inventory turns within target ~5; payables vs receivables improved +3 days sequentially and +16 days YoY

AI IconCapital Funding

  • Returned $6M to shareholders via dividends in Q2
  • No buyback executed in the quarter (management reiterated buybacks remain a full-year lever to offset dilution)
  • Ended Q2 with $315M cash; $134M cash net of debt
  • Maintained >$0.5B available borrowing capacity
  • Q2 cash flow: $35M operating cash flow; $22M free cash flow
  • Q2 capex approximately $13M; full-year capex expected 2%-2.5% of revenue

AI IconStrategy & Ops

  • Structural margin/earnings leverage targeted via disciplined OpEx and utilization improvements; variable compensation cited as impacting Q2 while overperformance supports continued leverage
  • Capacity expansion milestones: fourth PT facility in Penang ramping earlier than planned (ramping began in Q3 2026)
  • Thailand campus: planned groundbreaking for third building in Q3 2026; construction completion expected in Q4 2027
  • Working capital actions improving cash cycle and payables/receivables; inventory turns maintained ~5

AI IconMarket Outlook

  • 2026 revenue outlook increased to ~$3.0B, representing ~13% growth and historical high for the company
  • Q3 2026 revenue guidance: $755M-$795M
  • Q3 2026 non-GAAP EPS guidance: $0.76-$0.82 (midpoint implies ongoing growth)
  • Q3 non-GAAP gross margin guidance: 10.5%-10.7%; operating margin: 5.3%-5.5%
  • Q3 effective tax rate guidance: 26%-27%
  • Semi-Cap: second-half revenue growth expected to accelerate versus first half and prior year; momentum expected to continue throughout 2026
  • A&D: 2026 revenue expected roughly consistent with prior year; return to growth expected in 2027 after 2026 transition year driven by program timing within defense

AI IconRisks & Headwinds

  • Supply chain tightness: lead times increasing in certain components (memory and components dependent on fabs such as TSMC) from ~3-5 months to ~7-9 months and in some cases ~12 months
  • Operational risk of sustaining margin improvements despite variable compensation increases
  • A&D program transition year risk: 2026 expected transition performance tied to defense program timing (about 20% growth over prior two years, then timing-driven dip expected in first half)
  • Dependence on continued demand improvement across end markets; management acknowledged execution and supply-chain work remain necessary to sustain orders/bookings

Q&A: Analyst Interest

  • Aerospace/Defense bookings drivers: Management said defense environment remains strong and emphasized “replenishment” plus winning in both defense and space. It reiterated A&D team leadership in bookings this quarter, while not citing Iran-specific changes or budgets quantitatively. Response framed it as ongoing execution rather than macro hedges.
  • Supply chain lead-time changes: Management said lead times vary by component complexity and reliance on fabs (e.g., TSMC). It cited observed increases from roughly 3-5 months to 7-8-9 months, and up to ~12 months in some cases. The response highlighted proactive ordering and continuous supply chain work to protect fulfillment.
  • Medical “turn” and OpEx leverage: Management attributed Medical growth/turn to three catalysts: overall demand improvement, progress after channel inventory digestion, and a competitive takeaway described as a lift-and-shift engagement shortening time to revenue. OpEx trajectory emphasized continued leverage, with variable comp cited as a Q2 impact.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the BHE Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Benchmark Electronics, Inc. (BHE) Financial Profile